A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Neoplasm 50%
• Chemotherapy 50%
• Biological Marker 50%
• Adverse Event 50%
• Drug Action 50%
• Minimal Residual Disease 50%

Medicine and Dentistry

• Breast Cancer 100%
• Neoadjuvant Therapy 100%
• Neoplasm 20%
• Biological Marker 20%
• Adverse Event 20%
• Drug Action 20%
• Neoadjuvant Chemotherapy 20%
• Minimal Residual Disease 20%
• Effective Treatment 20%

Nursing and Health Professions

• Breast Cancer 100%
• Neoadjuvant Therapy 100%
• Biological Marker 20%
• Neoplasm 20%
• Adverse Event 20%
• Minimal Residual Disease 20%
• Neoadjuvant Chemotherapy 20%
• Drug Action 20%